Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2026-01-21 @ 12:38 PM
Study NCT ID:
NCT04969068
Status:
UNKNOWN
Last Update Posted:
2022-01-10
First Post:
2021-07-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Median Effective Dose of Remimazolam for Duodenoscopy Insertion During ERCP With Alfentanil 10µg/kg
Sponsor:
Tianjin Nankai Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-04
First Submit QC Date:
None
Study First Post Date:
2021-07-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-16
Last Update Post Date:
2022-01-10
Last Update Post Date Type:
ACTUAL